Photo: Pfizer and NovaMedica announce a strategic partnership in Russia

Print 13 July 2016

Pfizer, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by RMI and Domain Associates, have entered into an agreement to cooperate, signalling the development of a new partnership. Through this partnership, Pfizer proposes to invest in NovaMedica’s construction of a new manufacturing plant in the Kaluga region and license the technology for production of more than 30 medicinal products from its portfolio to the Russian partner.

Press conference: Announcement about the start of Pfizer and NovaMedica a long-term strategic partnership

Photo from right to left: Leonid Melamed, Head of Managing Company RMI Partners, Member of the Boards of Directors of NovaMedica, Brian Dovey, Partner at Domain Associates, Member of the Board of Directors of NovaMedica, Anatoly Chubais, Chairman of the Executive Board of RUSNANO, Chairman of the Board of Directors of NovaMedica, Petra Danielsohn-Weil, Regional President of Europe, Pfizer Essential Health Business, Andrey Trapesnikov, Deputy Chairman of the Executive Board of RUSNANO.

Photo: Petra Danielsohn-Weil, Regional President of Europe, Pfizer Essential Health Business, Anatoly Chubais, Chairman of the Executive Board of RUSNANO, Chairman of the Board of Directors of NovaMedica.

Photo: Anatoly Chubais, Chairman of the Executive Board of RUSNANO, Chairman of the Board of Directors of NovaMedica, Brian Dovey, Partner at Domain Associates, Member of the Board of Directors of NovaMedica.

Photo: Brian Dovey, Partner at Domain Associates, Member of the Board of Directors of NovaMedica.

Photo: Leonid Melamed, Head of Managing Company RMI Partners, Member of the Boards of Directors of NovaMedica

Photo: Press conference Announcement about the start of Pfizer and NovaMedica a long-term strategic partnership

All photos made by RUSNANO Press Center.

More picrures:

• 
• 
• 
• 

Return